Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8671808 | Journal of Vascular Surgery | 2018 | 21 Pages |
Abstract
Patients with multiple comorbidities and those undergoing type I or II TAAA repair are at greatest risk of mortality; however, in this high-risk population, F/B-EVAR offers greater survival compared with that reported for the natural history of untreated aneurysms. Operative and early mortality is lower than the best-reported open repair outcomes, even in this high-risk population, suggesting a potential benefit in extending the use of F/B-EVAR to low-to-average risk CAA patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jocelyn M. MD, Jeevanantham PhD, F. Ezequiel MD, Yuki RN, BSN, Corey MA, Eugene MD, Matthew J. MD,